Alnylam Pharmaceuticals ALNY Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $502.34M+318% | $278.1M+200% | $82.79M+125% | -$279.86M-284% | -$230.47M+30.6% | ||
| $54.81M-4.8% | $55.66M-1.8% | $56.32M+0.6% | $56.5M+2.1% | $57.56M+7.6% | ||
| $361.68M+27.6% | $348.24M+28.0% | $368.25M+65.6% | $305.84M+27.1% | $283.45M+24.8% | ||
| $714.9M+1,618% | $524.08M+6,405% | $265.86M— | -$15.54M— | -$47.11M— | ||
| $71.56M+136% | $58.7M+71.2% | $44.5M+9.9% | $36.55M-31.5% | $30.27M-50.6% | ||
| $334.18M— | $473.5M— | $420.59M— | -$110.77M— | —— | ||
| —— | —— | -$319.51M-206% | $231.59M-0.5% | $311.33M+101% | ||
| $690.17M— | $690.16M— | —— | —— | —— | ||
| $643.34M+931% | $465.38M+1,193% | $221.36M— | -$52.09M— | -$77.38M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Alnylam Pharmaceuticals generate?
- Alnylam Pharmaceuticals (ALNY) generated $714.9M in operating cash flow over the trailing twelve months.
- What is Alnylam Pharmaceuticals's free cash flow?
- After $71.6M of capital expenditures, Alnylam Pharmaceuticals's free cash flow was $643.3M over the trailing twelve months, up 931.4% year over year.
- Where does Alnylam Pharmaceuticals's cash flow data come from?
- Every line is extracted from Alnylam Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
